https://www.acc.org/latest-in-cardiology/articles/2021/08/16/14/55/shifting-the-diabetes-management-model
Shifting the Diabetes Management Model: Combination of Sodium-Glucose Cotransporter-2 Inhibitors...
sodium glucose cotransporterdiabetes management
https://www.scirp.org/journal/paperinformation?paperid=129978
Saudi Consensus on the Usage of Sodium-Glucose Cotransporter-2 Inhibitors on the Management of...
According to recent epidemiological data, chronic kidney diseases (CKDs) affect approximately 10% of the global population. Like many countries, CKD is a...
sodium glucose cotransporteron the
https://www.scirp.org/journal/paperinformation?paperid=136034
Sodium-Glucose Cotransporter-2 Inhibitors: Who, When & How? Guidance for Use from a...
Sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitors) have transformed diabetes management by targeting renal glucose reabsorption. Designed initially...
sodium glucose cotransporter
https://www.mdpi.com/2072-6643/16/22/3841
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal...
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) induce body weight loss, but their effect on skeletal muscle mass (SMM) and strength needs to...
sodium glucose cotransporter
https://openstax.org/books/pharmacology/pages/19-4-sodium-glucose-cotransporter-2-inhibitors-sglt2is
19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is) - Pharmacology for Nurses | OpenStax
Adverse effects of SGLT2Is include ketoacidosis in clients with diabetes mellitus, urinary tract infection, pyelonephritis, genital infection, necrotizi...
sodium glucose cotransporterpharmacology for nurses19 4
https://pmc.ncbi.nlm.nih.gov/articles/PMC7823667/
Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A...
Recent randomized controlled trials (RCTs) tested the efficacy of sodium-glucose cotransporter-2 (SGLT-2) inhibitors to specifically treat nonalcoholic fatty...
sodium glucose cotransporter
https://www.mdpi.com/2077-0383/13/4/1056
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment of Polycystic Ovary...
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women impacting their reproductive, mental, and metabolic health....
sodium glucose cotransporterthe role
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1102792/full
Frontiers | Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and...
Background: The relative efficacy of 9 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for n...
sodium glucose cotransporter